173 related articles for article (PubMed ID: 38227790)
1. Nucleic Acid-based Electrochemical Sensors Facilitate the Study of DNA Binding by Platinum (II)-based Antineoplastics.
Wu Y; Arroyo-Currás N
Angew Chem Int Ed Engl; 2024 Mar; 63(12):e202312402. PubMed ID: 38227790
[TBL] [Abstract][Full Text] [Related]
2. Rational design of dicarboxylato platinum(II) complexes with purine-mimetic ligands as novel anticancer agents.
Hoffmann K; Wiśniewska J; Wojtczak A; Sitkowski J; Denslow A; Wietrzyk J; Jakubowski M; Łakomska I
J Inorg Biochem; 2017 Jul; 172():34-45. PubMed ID: 28477537
[TBL] [Abstract][Full Text] [Related]
3. Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells.
Cetraz M; Sen V; Schoch S; Streule K; Golubev V; Hartwig A; Köberle B
Arch Toxicol; 2017 Feb; 91(2):785-797. PubMed ID: 27307157
[TBL] [Abstract][Full Text] [Related]
4. A Click Chemistry Approach to Targeted DNA Crosslinking with cis-Platinum(II)-Modified Triplex-Forming Oligonucleotides.
Hennessy J; McGorman B; Molphy Z; Farrell NP; Singleton D; Brown T; Kellett A
Angew Chem Int Ed Engl; 2022 Jan; 61(3):e202110455. PubMed ID: 34652881
[TBL] [Abstract][Full Text] [Related]
5. Fabrication of electrochemical DNA sensors on gold-modified recessed platinum nanoelectrodes.
Salamifar SE; Lai RY
Anal Chem; 2014 Mar; 86(6):2849-52. PubMed ID: 24559231
[TBL] [Abstract][Full Text] [Related]
6. DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation.
Roy S; Maheswari PU; Lutz M; Spek AL; den Dulk H; Barends S; van Wezel GP; Hartl F; Reedijk J
Dalton Trans; 2009 Dec; (48):10846-60. PubMed ID: 20023915
[TBL] [Abstract][Full Text] [Related]
7. Folding- and Dynamics-Based Electrochemical DNA Sensors.
Lai RY
Methods Enzymol; 2017; 589():221-252. PubMed ID: 28336065
[TBL] [Abstract][Full Text] [Related]
8. Anomalous Trends in Nucleic Acid-Based Electrochemical Biosensors with Nanoporous Gold Electrodes.
Veselinovic J; Almashtoub S; Seker E
Anal Chem; 2019 Sep; 91(18):11923-11931. PubMed ID: 31429540
[TBL] [Abstract][Full Text] [Related]
9. DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)].
Brabec V; Christofis P; Slámová M; Kostrhunová H; Nováková O; Najajreh Y; Gibson D; Kaspárková J
Biochem Pharmacol; 2007 Jun; 73(12):1887-900. PubMed ID: 17400194
[TBL] [Abstract][Full Text] [Related]
10. The role of bridging ligands in determining DNA-binding ability and cross-linking patterns of dinuclear platinum(II) antitumour complexes.
Zhu J; Lin M; Fan D; Wu Z; Chen Y; Zhang J; Lu Y; Guo Z
Dalton Trans; 2009 Dec; (48):10889-95. PubMed ID: 20023919
[TBL] [Abstract][Full Text] [Related]
11. An Electrochemical DNA Biosensor for Carcinogenicity of Anticancer Compounds Based on Competition between Methylene Blue and Oligonucleotides.
Md Sani ND; Ariffin EY; Sheryn W; Shamsuddin MA; Heng LY; Latip J; Hasbullah SA; Hassan NI
Sensors (Basel); 2019 Nov; 19(23):. PubMed ID: 31766637
[TBL] [Abstract][Full Text] [Related]
12. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
[TBL] [Abstract][Full Text] [Related]
13. Use of top-down and bottom-up Fourier transform ion cyclotron resonance mass spectrometry for mapping calmodulin sites modified by platinum anticancer drugs.
Li H; Lin TY; Van Orden SL; Zhao Y; Barrow MP; Pizarro AM; Qi Y; Sadler PJ; O'Connor PB
Anal Chem; 2011 Dec; 83(24):9507-15. PubMed ID: 22032417
[TBL] [Abstract][Full Text] [Related]
14. Survey of Redox-Active Moieties for Application in Multiplexed Electrochemical Biosensors.
Kang D; Ricci F; White RJ; Plaxco KW
Anal Chem; 2016 Nov; 88(21):10452-10458. PubMed ID: 27659949
[TBL] [Abstract][Full Text] [Related]
15. Beyond platinums: gold complexes as anticancer agents.
Nardon C; Boscutti G; Fregona D
Anticancer Res; 2014 Jan; 34(1):487-92. PubMed ID: 24403506
[TBL] [Abstract][Full Text] [Related]
16. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
Kasparkova J; Novakova O; Farrell N; Brabec V
Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
[TBL] [Abstract][Full Text] [Related]
17. [Drug discovery research in in-vivo antitumor-active azolato-bridged dinuclear Pt(II) complexes].
Komeda S
Yakugaku Zasshi; 2012; 132(3):253-9. PubMed ID: 22382827
[TBL] [Abstract][Full Text] [Related]
18. The Application of ATR-FTIR Spectroscopy and the Reversible DNA Conformation as a Sensor to Test the Effectiveness of Platinum(II) Anticancer Drugs.
Al-Jorani K; Rüther A; Martin M; Haputhanthri R; Deacon GB; Li HL; Wood BR
Sensors (Basel); 2018 Dec; 18(12):. PubMed ID: 30563229
[TBL] [Abstract][Full Text] [Related]
19. Binding of platinum derivative, oxaliplatin to deoxyribonucleic acid: structural insight into antitumor action.
Ray B; Gupta B; Mehrotra R
J Biomol Struct Dyn; 2019 Sep; 37(14):3838-3847. PubMed ID: 30282523
[TBL] [Abstract][Full Text] [Related]
20. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
